Sert U Yasemin, Buyuk Gul Nihal, Engin Ustun Yaprak, Ozgu Erdinc A Seval
University of Health Science, Zekai Tahir Burak Women's Health Care Training and Research Hospital, Department of Obstetrics and Gynecology, Ankara, Turkey.
University of Health Sciences, Zekai Tahir Burak Women's Health Care Training and Research Hospital, Department of Obstetrics and Gynecology, Ankara, Turkey.
Medeni Med J. 2020;35(3):195-201. doi: 10.5222/MMJ.2020.29964. Epub 2020 Sep 30.
To determine the levels of thyroid-stimulating hormone (TSH), thyroxin (T4), triiodothyronine (T3), anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-TG) and renal iodine excretion (RIE) in the first trimester of the pregnancy and to estimate the risk of developing GDM in these patients.
The levels of TSH, T3, T4, anti-TPO, anti-TG, and RIE were retrospectively evaluated. A total of 312 pregnant women were included in the study (GDM (-) group n=240, GDM (+) group n=62). Diagnosis of GDM was made according to the recommendation of American Diabetes Organization (ADA). The association between thyroid dysfunction and GDM was evaluated.
Our study included a total of 302 women. Sixty-two of these women were diagnosed as GDM (62/302=20.5%). When compared with the GDM (-) group the mean TSH level (2.02 vs 4.13 p=0.019), anti-TPO positivity (8.3% vs 30.64% p=0.044), anti-TG positivity (8.3% vs 19.4% p=0.019) and RIE (156 vs 178 p=0.017) were significantly higher in the GDM (+) group. TSH levels were statistically significantly higher in patients with positive anti-TPO levels (P=0.045).
Elevated TSH levels , TPO and TG antibody positivity rates were more frequent among the patients with GDM. These results may be a guide to perform routine thyroid function tests for patients with increased risk of GDM, on the other hand, they will alert the physicians for GDM progression and ensure taking preventive attempts for the patients who have thyroid disorder, especially those with positive thyroid antibodies in the first trimester of the pregnancy.
测定妊娠早期促甲状腺激素(TSH)、甲状腺素(T4)、三碘甲状腺原氨酸(T3)、抗甲状腺过氧化物酶(抗-TPO)、抗甲状腺球蛋白(抗-TG)水平及肾脏碘排泄量(RIE),并评估这些患者发生妊娠期糖尿病(GDM)的风险。
回顾性评估TSH、T3、T4、抗-TPO、抗-TG及RIE水平。共有312名孕妇纳入研究(GDM(-)组n = 240,GDM(+)组n = 62)。GDM的诊断依据美国糖尿病协会(ADA)的建议。评估甲状腺功能障碍与GDM之间的关联。
我们的研究共纳入302名女性。其中62名女性被诊断为GDM(62/302 = 20.5%)。与GDM(-)组相比,GDM(+)组的平均TSH水平(2.02对4.13,p = 0.019)、抗-TPO阳性率(8.3%对30.64%,p = 0.044)、抗-TG阳性率(8.3%对19.4%,p = 0.019)及RIE(156对178,p = 0.017)显著更高。抗-TPO水平阳性的患者TSH水平在统计学上显著更高(P = 0.045)。
GDM患者中TSH水平升高、TPO和TG抗体阳性率更为常见。这些结果可能为GDM风险增加的患者进行常规甲状腺功能检查提供指导,另一方面,它们将提醒医生注意GDM的进展,并确保对患有甲状腺疾病的患者,尤其是妊娠早期甲状腺抗体阳性的患者采取预防措施。